Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Oncolytics Biotech (ONCY)

Oncolytics Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONCY
DateTimeSourceHeadlineSymbolCompany
07/03/202421:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
05/03/202418:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
04/03/202417:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
28/02/202418:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
14/02/202413:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
09/01/202413:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
04/01/202418:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
07/12/202315:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
09/11/202318:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
09/11/202318:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
03/11/202318:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
03/11/202315:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
03/11/202315:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
23/10/202317:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
23/10/202317:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
20/10/202320:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
16/10/202318:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
26/09/202317:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
26/09/202313:00PR Newswire (US)THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSNASDAQ:ONCYOncolytics Biotech Inc
19/09/202322:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
06/09/202317:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
14/08/202314:49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
14/08/202313:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
04/08/202320:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
04/08/202319:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
22/06/202314:23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
05/06/202312:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
26/05/202316:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
26/05/202311:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
11/05/202320:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:ONCY